<DOC>
	<DOCNO>NCT01625806</DOCNO>
	<brief_summary>This single-center , open-label , parallel group study evaluate effect multiple dos ketoconazole pharmacokinetics single oral dose RO4602522 healthy male volunteer . All subject receive single oral dose RO4602522 Day 1 . Subjects assign Group 2 additionally receive ketoconazole ( 200 mg orally every 12 hour ) Day 1 Day 17 .</brief_summary>
	<brief_title>A Study The Effects Multiple Doses Ketoconazole Single Dose Pharmacokinetics RO4602522 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Healthy male subject , 18 45 year age , inclusive Healthy status define absence evidence active chronic disease follow detailed medical surgical history complete physical examination Body mass index ( BMI ) 18 30 kg/m2 inclusive Male subject partner childbearing potential must use two method contraception , one must barrier method , duration study 90 day last dose Nonsmoker ( smoke since least 3 month prior screen ) History alcohol abuse drug addiction ( include soft drug like cannabis product ) Positive hepatitis B , hepatitis C , HIV infection Participation investigational drug device study within 90 day prior screen Concomitant disease condition could interfere , treatment might interfere conduct study , would , opinion investigator , pose unacceptable risk subject study History disease condition could alter absorption , metabolism elimination drug Positive drug test and/or positive alcohol test Positive cotinine test Subject likely need concomitant medication study period ( include dental condition ) Any confirmed significant allergic reaction drug , multiple allergy judgment investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>